Prescription brands have dramatically boosted their multiscreen TV advertising spend following a federal enforcement action against deceptive drug advertisers, according to an analysis by the
Video Advertising Bureau, PPC Land reports. From October 2025 through March 2026, pharma Rx brands spent $4.95 billion on multiscreen TV advertising, a 53% increase over the
$3.23 billion invested during the same period in the prior year.